Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma and Cetuximab-induced Papulopustular (Acneiform) Rash Who Have Clinical Trial Using Topical Dapsone 5% Gel, Moisturizer and oral antibiotics

- The folks at Memorial Sloan-Kettering Cancer Center are studying the effects of Topical Dapsone 5% Gel; Moisturizer; oral antibiotics on Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma and Cetuximab-induced Papulopustular (Acneiform) Rash Who Have in individuals ages 18 years and older. This clinical trial is slated to start August 2013 and is expected to end circa August 2015.

212-610-0079
Overall Study Contact Info
StatusName Contact Phone
RecruitingMario Lacouture, MD212-610-0079

This study is officially titled, "A Phase III Randomized Double-blind Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT."

Locations

Memorial Sloan-Kettering Cancer Center

New York, New York - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.